RAB1C

Across TCGA pan-cancer cohorts, RAB1C RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RAB1C data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RAB1C RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RAB1C expression acts as an unfavorable survival marker, although some lineages such as KIRC and SKCM show a favorable association.

KIRC, SKCM, and KIRP are the cancer types where RAB1C RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.729	0.525	<.001	82	view →
SKCM	OS	Quartile	III,IV	0.734	0.277	.001	26	view →
KIRP	DFS	Tertile	III,IV	0.718	0.403	.005	26	view →
CHOL	OS	Median	III,IV	1.000	0.286	.008	21	view →
LGG	OS	Quartile	All	0.674	0.900	.002	19	view →
CESC	OS	Median	All	0.857	0.737	.006	16	view →
MESO	OS	Quartile	All	0.650	0.178	.026	15	view →
ACC	DFS	Quartile	All	0.600	0.824	.019	13	view →
LUSC	OS	Median	All	0.470	0.334	.002	11	view →
READ	OS	Tertile	IV	0.371	0.889	.010	6	view →
UCEC	DFS	Quartile	III,IV	0.848	0.721	.029	6	view →
LUAD	OS	Median	All	0.774	0.846	.010	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RAB1C–KIRC (DFS)

Open the KIRC breakdown →